sb 203580 has been researched along with edelfosine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (edelfosine) | Trials (edelfosine) | Recent Studies (post-2010) (edelfosine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 454 | 7 | 85 |
| Protein | Taxonomy | sb 203580 (IC50) | edelfosine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | 1.8 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Ito, T; Kato, K; Kozawa, O; Matsuno, H; Niwa, M; Sakai, N; Tanabe, K; Uematsu, T | 1 |
1 other study(ies) available for sb 203580 and edelfosine
| Article | Year |
|---|---|
p38 MAP kinase is required for vasopressin-stimulated HSP27 induction in aortic smooth muscle cells.
Topics: Animals; Aorta; Arginine Vasopressin; Cell Line; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Imidazoles; Immunoassay; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Naphthalenes; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Phospholipid Ethers; Phosphorylation; Protein Kinase C; Pyridines; RNA, Messenger; Tetradecanoylphorbol Acetate; Vasopressins | 2000 |